Chronic & Pressure Wounds

The Problem

Chronic wounds and pressure ulcers (bedsores) are frequent among immobilized or elderly patients.

These wounds are commonly colonized by resistant bacteria, forming chronic inflammation and poor healing despite topical care.

The GentaGel™ Solution

  • Sustained bactericidal antibiotic levels in the wound bed.
  • Reduced bacterial load & inflammation promoting granulation and closure.
  • Biodegradable and safe for repeated local applications.
  • Improves patient comfort and quality of life.

Market Impact (U.S.)​

~2.5M

Annual patients in the U.S. market

~65K

Will undergo surgical debridement (advanced Stage 3–4 cases)

~50%

Will need more procedures

~$9.0B

Total healthcare costs of these ulcers in the U.S. market